-
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts
ソース: Buzz FX / 06 2 2025 04:56:09 America/New_York
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 6, 2025 Share Link copied to clipboard. Esperion Therapeutics, Inc.
Read more...